Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket

Benzinga11/19 19:30

Enveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders

Benzinga11/18 23:06

Enveric Biosciences 3Q Loss/Shr 24c >ENVB

Dow Jones11/15 05:23

エンベリック・バイオサイエンシズ | 10-Q：Q3 2024 四半期報告書

SEC11/15 05:17

Enveric Biosciences Canada Granted U.S. Patent #12138276: Halogenated Psilocybin Derivatives and Methods of Using

Benzinga11/13 05:22

Enveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal

Benzinga11/12 22:00